Scholars Central

Conference abstractPublished 8 Aug 2016

Integration of genomics with metabolomics and epigenomics and its implication in cancer control

Authors: Mukesh Verma

National Cancer Institute-National Institutes of Health, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Precision medicine is an emerging science with the potential to improve early cancer diagnosis and enable the development of treatment based on an individualâÂ?Â?s genetic background, family history and other characteristics. Identifying patients who may benefit from personalized and precision therapy depends on identifying accurate assays for the biomarkers that are needed to determine optimal treatment. Compared to the rapid progress in technology development, the progress in treatment timing has been slow. Most clinicians rely on pathology reports that become available in due time, which often is too late to control or treat cancer. Molecular profiling (mostly omics profiling based on genomics, metabolomics, epigenomics, transcriptomics and glycomics data) and molecular classification of cancer can be achieved in real time and may help to identify those cancer-associated biomarkers that are expressed much earlier than pathological symptoms and characteristics appear in histopathological analyses. Once these biomarkers are included in personalized medicine, it will enable treatment to be implemented earlier, which will produce better outcomes. Although the traditional approach to personalized medicine has been âÂ?Â?reactiveâÂ? in the future, it will be âÂ?Â?Proactive.âÂ? These approaches might be useful in controlling cancer which is a priority at the National Cancer Institute (NCI) and the National Institutes of Health (NIH). An update from the Common Fund Metabolomics, Epigenomics Roadmap, Molecular Transducers of Physical Activity and the Cancer Genome Atlas (TCGA) will be presented.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Mukesh Verma”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels